Bausch Health Companies (BHC) Non Operating Interest Expenses (2009 - 2026)

Bausch Health Companies has disclosed Non Operating Interest Expenses across 18 years of filings, most recently posting $396.0 million for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 14.84% year-over-year to $396.0 million; the TTM figure through Jun 2026 stood at $1.6 billion (up 8.73% YoY), while the FY2025 annual figure was $1.6 billion, up 15.56% from the prior year.
• Non Operating Interest Expenses came in at $396.0 million for Q2 2026 at Bausch Health Companies, down from $402.0 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $465.0 million in Q2 2025 to a low of $307.0 million in Q4 2022.
• Average Non Operating Interest Expenses over 5 years is $365.7 million, with a median of $358.5 million recorded in 2022.
• Year-over-year, Non Operating Interest Expenses slipped 22.2% in 2023 and jumped 32.86% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $307.0 million in 2022, then climbed by 18.24% to $363.0 million in 2023, then fell by 7.16% to $337.0 million in 2024, then climbed by 17.8% to $397.0 million in 2025, then declined by 0.25% to $396.0 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $396.0 million in Q2 2026, $402.0 million in Q1 2026, and $397.0 million in Q4 2025.